Mortality due to diabetes mellitus in the municipality of Colon, province of Matanzas. 2011-2021
Keywords:
mortality, diabetes mellitus, causes of deathAbstract
Introduction: diabetes mellitus, considered one of the main health problems worldwide, is among the diseases resulting more expensive to society, because of its high and early mortality.
Objective: to characterize the behavior of mortality caused by diabetes mellitus in the municipality of Colon, in the last eleven years.
Materials and methods: descriptive, retrospective study of the database of deaths from the Municipal Health Department of the municipality of Colon, from January 1st 2011 to December 31st, 2021. 221 subjects with diabetes mellitus with diabetes mellitus main cause of death were chosen. The independent variables were: year of death, gender, age and direct cause of death. The results were analyzed using descriptive statistics, through SPSS package.
Results: increasing tendency of mortality, more accentuated in 2021, when 38 diabetic patients died. Women (134) predominated over men (87) and predominated also the age group of 65 years and over (67.4 %). Hearth diseases (24 %), bronchopneumonia (20.4 %), and chronic renal failure (14.9 %) were identified as more frequent causes of death.
Conclusions: mortality due to diabetes mellitus has showed an increasing tendency during the last eleven years; the predominance in women, people over 65 years, and hearth diseases as direct causes of death characterized its behavior.
Downloads
References
2. Pérez Jiménez D, Gámez Sánchez D. Estado actual de la mortalidad por diabetes mellitus en el mundo y en Cuba [Internet]. Presentado en: III Convención Internacional de Salud Pública Cuba Salud 2018; 23-27 abr 2018; La Habana [citado 06/06/2021]. Disponible en: http://www.convencionsalud2018.sld.cu/index.php/connvencionsalud2018/paper/view/1800
3. Li B, Yang J, Zhao F, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol [Internet]. 2020 [citado 06/06/2021];109(5):531-8. Disponible en: https://doi.org/10.1007/s00392-020-01626-9
4. Ministerio de Salud Pública. Dirección de Registros Médicos y Estadísticas de Salud. Anuario Estadístico de Salud 2020 [Internet]. La Habana: Dirección Nacional de Estadísticas; 2021 [citado 06/06/2021]. Disponible en: https://salud.msp.gob.cu/wp-content/Anuario/Anuario-2020.pdf
5. Díaz Díaz O, Mateo de Acosta O. Programa Nacional de Diabetes. [Internet]. La Habana: Comisión Nacional de Diabetes; 2000 [citado 25/01/2020]. Disponible en: https://extranet.who.int/ncdccs/Data/CUB_B6_Programa%20Nacional%20de%20Diabetes%20Cuba..pdf
6. Centers for Disease Control and Prevention. Underlying Cause of Death 1999-2020 [Internet]. Georgia: CDC WONDER; 2018 [citado 06/06/2021]. Disponible en: https://wonder.cdc.gov/ucd-icd10.html
7. Magliano DJ, Islam RM, Barr ELM, et al. Trends in incidence of total or type 2 diabetes: systematic review. BMJ. 2019;366:l5003. Citado en PubMed; PMID: 31511236.
8. Núñez González S, Delgado Ron A, Simancas Racines D. Tendencias y análisis espacio-temporal de la mortalidad por Diabetes Mellitus en Ecuador, 2001-2016. RCSP [Internet]. 2020 [citado 09/01/2022];46(2). Disponible en: http://www.revsaludpublica.sld.cu/index.php/spu/article/view/1314
9. Quesada Marelys Y. Diabetes mellitus: un problema de salud en Cuba. Rev Cubana Med [Internet]. 2019 [citado 23/03/2021];58(4):1319. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75232019000400001&lng=es
10. Aguilar-Gamboa FR, Suclupe-Campos DO, Vega-Fernández JA. Sindemia por COVID-19 y diabetes mellitus tipo II: una peligrosa interacción. Rev Electrón Dr. Zoilo E. Marinello Vidaurreta [Internet]. 2021 [citado 13/08/2022];46(3). Disponible en: http://revzoilomarinello.sld.cu/index.php/zmv/article/view/2742
11. Resúmenes sobre diabetes y género. Rev Cubana Med Gen Integr [Internet]. 2009 [citado 17/01/2022];25(2). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21252009000200014&lng=es
12. Weng W, Kong SX, Ganguly R, et al. The prevalence of cardiovascular disease by vascular bed and impact on healthcare costs in a large, real-world population with type 2 diabetes. Endocrinol Diabetes Metab. 2020;3(2):00106. Citado en PubMed; PMID: 32318629.
13. García García Y. Riesgo cardiovascular en personas con diabetes mellitus. Rev Cubana Endocrinol [Internet]. 2017 [citado 18/01/2021];28(3):1-6. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-29532017000300001&lng=es
14. Pereira Despaigne OL, Palay Despaigne MS, Rodríguez Cascaret A, et al. La diabetes mellitus y las complicaciones cardiovasculares. Medisan [Internet]. 2015 [citado 18/11/2021];19(5):675-83. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192015000500013&lng=es
15. Guamán C, Acosta W, Álvarez C, et al. Diabetes y enfermedad cardiovascular. Rev Urug Cardiol [Internet]. 2021 [citado 18/11/2021];36(1):401. Disponible en: http://www.scielo.edu.uy/scielo.php?script=sci_arttext&pid=S1688-04202021000101401&lng=es
16. Gupta R, Ghosh A, Singh AK, et al. Clinical considerations for patients with diabetes in times of COVID-19 epidemic. Diabetes Metab Syndr. 2020;14(3):211-2. Citado en PubMed; PMID: 32172175.
17. Guo W, Li M, Dong Y, et al. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev. 2020;36(7):3319. Citado en PubMed; PMID: 32233013.
18. Díaz E, Martín Loeches I, Vallés J. Neumonía nosocomial. Enferm Infecc Microbiol Clin [Internet]. 2013 [citado 18/05/2019];31(10):692-8. Disponible en: https://www.elsevier.es/es-revista-enfermedades-infecciosas-microbiologia-clinica-28-articulo-neumonia-nosocomial-S0213005X13001316
19. File TM. Epidemiology, pathogenesis, and microbiology of community-acquired pneumonia in adults. UpToDate; 2020 [actualizado 08/2022; citado 17/01/2022]. Disponible en: https://www.uptodate.com/contents/epidemiology-pathogenesis-and-microbiology-of-community-acquired-pneumonia-in-adults
20. Barrera Salas M, Morales Hernández AE, Hernández Osorio JJ, et al. Inmunosenescencia. Med interna Méx [Internet]. 2017 [citado 17/01/2022];33(5):696-704. Disponible en: https://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0186-48662017000500696&lng=es
21. Fülöp T, Dupuis G, Witkowski JM, et al. The Role of Immunosenescence in the Development of Age-Related Diseases. Rev Invest Clin. 2016;68(2):84-91. Citado en PubMed; PMID: 27103044.
22. Álvarez L, Arnold Y. Envejecimiento poblacional y efecto en la diabetes mellitus en Cuba. Rev Cientif Inst Invest Qim Biol [Internet]. 2016 [citado 18/11/2021];26(1):71-7. Disponible en: http://www.revistasguatemala.usac.edu.gt/index.php/qyf/article/view/469
23. Aldrete Velasco JA, Chiquete E, Rodríguez García JA, et al. Mortalidad por enfermedad renal crónica y su relación con la diabetes en México. Med interna Méx [Internet]. 2018 [citado 17/01/2022];34(4):536-50. Disponible en: https://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0186-48662018000400004&lng=es
24. Fiterre Lancis I, Fernández Vega García S, Rivas Sierra RA, et al. Mortalidad en pacientes con enfermedad renal. Instituto de Nefrología. 2016 y 2017. Rev haban cienc méd [Internet]. 2019 [citado 02/09/2022];18(2):[aprox. 13 pantallas]. Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/2520
25. Martínez Candela J, Sangrós González J, García Soidán FJ, et al. Enfermedad renal crónica en España: prevalencia y factores relacionados en personas con diabetes mellitus mayores de 64 años. Nefrología [Internet]. 2018 [citado 17/01/2022];38(4):401-13. Disponible en: https://www.sciencedirect.com/science/article/pii/S0211699518300110
Downloads
Published
How to Cite
Issue
Section
License
All content published in this journal is Open Access, distributed under the terms of the CC BY-NC 4.0 License.
It allows:
- Copy and redistribute published material in any medium or format.
- Adapt the content.
This will be done under the following terms:
- Attribute the authors' credits and indicate whether changes were made, in which case it must be in a reasonable way.
- Non-commercial use.
- Recognize the journal where it is published.
The copyrights of each article are maintained, without restrictions.
Guidelines to authors
